Decades of work by husband-and-wife team yields new Parkinson's drug (IMAGE)
Caption
The federal Food and Drug Administration has approved a new Parkinson’s disease drug that was based on research by UVA Health scientists. The drug tavapadon, now branded Juvmo, was pioneered by University of Virginia School of Medicine Professor of Pharmacology and Neuroscience Richard B. Mailman, PhD. UVA Health’s Xuemei Huang, MD, PhD, chair of the Department of Neurology, also played a vital role in the first successful clinical trial with a drug of this class.
Credit
UVA Health
Usage Restrictions
May be used to accompany news coverage of the Parkinson's drug development. All other uses require express written consent from UVA Health.
License
Original content